J. Maloney

发表

Characterization of a Common Susceptibility Locus for Asthma-related Traits Vascular Endothelial Growth Factor (vegf) Induces Remodeling and Enhances Th2-mediated Sensitization and Inflammation in the Lung

J. Maloney, 2022 .

Plasma vascular endothelial growth factor in acute mountain sickness.

N. Voelkel, S. Ruoss, J Maloney, 2000, Chest.

In vitro release of vascular endothelial growth factor during platelet aggregation.

N. Voelkel, R. Tuder, C. Silliman, 1998, The American journal of physiology.

Characterization of a Common Susceptibility Locus for Asthma-related Traits Vascular Endothelial Growth Factor (vegf) Induces Remodeling and Enhances Th2-mediated Sensitization and Inflammation in the Lung

J. Maloney, 2022 .

Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.

A. Bredenoord, E. Dellon, I. Hirano, 2023, The lancet. Gastroenterology & hepatology.

Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.

G. Yancopoulos, M. Bafadhel, S. Bhatt, 2023, The New England journal of medicine.

Dupilumab demonstrated efficacy and was well tolerated regardless of prior use of swallowed topical corticosteroids in adolescent and adult patients with eosinophilic oesophagitis: a subgroup analysis of the phase 3 LIBERTY EoE TREET study

A. Bredenoord, I. Hirano, A. Shabbir, 2023, Gut.

Dupilumab treatment improves signs, symptoms, quality of life and work productivity in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial.

B. Akinlade, J. Maloney, D. Delevry, 2024, Journal of the American Academy of Dermatology.

Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy

Kaitlyn M. Gayvert, M. Wipperman, J. Orengo, 2024, Allergy.